AssetMark Inc
TNDM icon

AssetMark Inc’s Tandem Diabetes Care TNDM Stock Holding History

AssetMark Inc’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Hold
1,750
– – ﹤0.01% 2079
2026
Q1 		$33.5K Hold
1,750
– – ﹤0.01% 1878
2025
Q4 		$38.5K Hold
1,750
– – ﹤0.01% 1798
2025
Q3 		$21.2K Hold
1,750
– – ﹤0.01% 1898
2025
Q2 		$32.6K Hold
1,750
– – ﹤0.01% 1681
2025
Q1 		$33.5K Buy
1,750
+525
+43% +$15.4K ﹤0.01% 1555
2024
Q4 		$44.1K Buy
1,225
+535
+78% +$18.1K ﹤0.01% 1455
2024
Q3 		$29.3K Buy
+690
New +$29.3K ﹤0.01% 1417

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

AssetMark Inc's TNDM Position: Q2 2026 in Review

AssetMark Inc held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 1,750 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

AssetMark Inc first reported a position in TNDM in Q3 2024 and has held it in 8 quarters since. The position peaked at $44.1K in Q4 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • AssetMark Inc held 1,750 shares of Tandem Diabetes Care worth $26.4K as of Q2 2026.
  • AssetMark Inc left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2079 holding.
  • AssetMark Inc first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 8 quarters since.
  • AssetMark Inc's Tandem Diabetes Care position peaked at $44.1K in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.